Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK2295 for postoperative dental pain
NCT00387140Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-2295 in odontalgia, sponsored by Merck & Co.. Started Oct 2006; status: completed.
02
Drugs
MK-2295
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT00387140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387140.